African Regulator Approves Continent's First Test for Mpox Developed by Morocco

The Central African region, which includes the Democratic Republic of Congo—the epicenter of the outbreak—accounts for 85.7% of infections and 99.5% of deaths on the continent. The new strain of mpox is now also spreading in Europe, where it has been detected in Sweden, Germany and the United Kingdom.
Sputnik
The Africa Centers for Disease Control and Prevention (Africa CDC) has approved the first mpox test developed on the continent. It was invented and researched in Morocco, according to a press release by the African regulator.

"The Africa Centers for Disease Control and Prevention through its Diagnostic Advisory Committee (DAC) has recommended the first locally manufactured Real-Time PCR test for mpox from Morocco. Africa CDC’s approval underscores the test’s reliability and efficacy, potentially boosting Morocco’s role in global health initiatives," the Africa CDC said.

Sub-Saharan Africa
African Disease Control Agency Calls on US to Deliver Promised Support as Mpox Risks Rise in Africa
The organization added, "This major milestone is in line with the African Union’s continental effort to strengthen the self-sufficiency of African public health systems towards enhancing the continent’s efficiency in preparedness and response to disease threats."
Earlier, the Africa CDC announced that the number of mpox infections in Africa has increased by 500% compared to last year. About 50,000 cases of the viral infection have been recorded in 19 countries across the continent, while the number of deaths has totaled 1,048.